Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 -
EBIT 2015 -35,3 M
Net income 2015 -35,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 3,33 M
EBIT 2016 -46,2 M
Net income 2016 -46,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 50,6x
Capitalization 169 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Latest news on ANTA PHAR
04/14 ANTHERA PHARMACEUTICALS : Updates on Biotech Stocks -- Gilead Sciences, Arena Ph..
04/01 ANTHERA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stoc..
03/28 ANTHERA PHARMACEUTICALS : Reports Proposed Public Offering of Common Stock
03/25 ANTHERA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
03/25 ANTHERA PHARMACEUTICALS : Reports 2014 Fourth Quarter and Fiscal Year Financial ..
03/25 ANTHERA PHARMACEUTICALS : Announces $3 Million Research Award from Cystic Fibros..
03/25 ANTHERA PHARMACEUTICALS : Announces Completion of Interim Analysis from Phase 3 ..
03/23 ANTHERA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stoc..
More news
Sector news : Biopharmaceuticals
05:53pDJApple Dives Again Into Bond Market -- 2nd Update
04:57pDJU.S. Stocks End Lower
03:58pDJAlexion-Synageva Deal Shows Lure of Rare-Disease Drugs -- 3rd Update
More sector news : Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF